Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Pulmonary Hypertension, September 2025 Free Subscription Abstracts Retrieve all available abstracts of the following 155 articles: HTML format

Single Articles

1. WESTHOFF M, Hardebusch T, Breithecker A, Steudel B, et al
   Klippel-Trenaunay Syndrome with Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty.
   Pneumologie. 2025 Aug 29. doi: 10.1055/a-2681-5486.
   PubMed    
   Abstract available
   
   

2. CHEN L, Zhou S, Wang J, Hu S, et al
   Analysis of Clinical Characteristics of 54 Dead Pregnant Patients With Pulmonary Hypertension.
   Pulm Circ. 2025;15:e70123.
   PubMed    
   Abstract available
   
   

3. RICCHI B, Jagana V, Singh E, Ochoa MT, et al
   Advances in diagnosis and patient profiling in pulmonary arterial hypertension for precision medicine.
   Ther Adv Respir Dis. 2025;19:17534666251367312.
   PubMed    
   Abstract available
   
   

4. SANTI M, Madonna R
   Unbiased serum proteomics in heart failure and associated pulmonary hypertension: From biomarkers discovery to precision medicine.
   Eur J Clin Invest. 2025 Aug 29:e70115. doi: 10.1111/eci.70115.
   PubMed    
   Abstract available
   
   

5. GUO G, Zhu MX, Xu X, Li X, et al
   PHPT1 acts as an inhibitor in high-altitude pulmonary hypertension via negative TRPV5 signaling regulation.
   J Transl Med. 2025;23:968.
   PubMed    
   Abstract available
   
   

6. SANTOS RT, Braga CL, de Sa Freire Onofre ME, da Silva CM, et al
   Cardioprotective effects of extracellular vesicles from hypoxia-preconditioned mesenchymal stromal cells in experimental pulmonary arterial hypertension.
   Stem Cell Res Ther. 2025;16:466.
   PubMed    
   Abstract available
   
   

7. ZONENBERG A, Ptaszynska K, Szwedowicz A, Sawicka-Smiarowska E, et al
   Linking cardiological parameters and choroidal changes in patients with precapillary pulmonary hypertension: a cross-sectional study.
   Sci Rep. 2025;15:31693.
   PubMed    
   Abstract available
   
   

8. AHMED S, Liu E, Eberhard B, Villela-Franyutti D, et al
   The Obstetric Comorbidity Index (OB-CMI) and its association with ICU admission and length of hospital stay in pregnant patients with pulmonary hypertension: a retrospective cohort study (1996-2025).
   Int J Obstet Anesth. 2025;64:104751.
   PubMed    
   Abstract available
   
   

9. HAN W, Ban Q, Zhai D, Zhai Y, et al
   Late Gadolinium Enhancement on Cardiac MRI and the Prognosis of Patients With Pulmonary Hypertension: A Meta-Analysis.
   Echocardiography. 2025;42:e70278.
   PubMed    
   Abstract available
   
   

10. KOLODZEY G, Peter A, Darago A, Balogh L, et al
    Assessment of Right Ventricular Pressure in Chronic Thromboembolic Pulmonary Hypertension: Comparison of Diagnostic Modalities and Balloon Pulmonary Angioplasty Outcomes.
    Diagnostics (Basel). 2025;15:2050.
    PubMed    
    Abstract available
    
    

11. FUMINI V, Bonora R, Busciglio A, Cartisano F, et al
    Prenatal Rare 16q24.1 Deletion Between Genomics and Epigenetics: A Review.
    Genes (Basel). 2025;16:873.
    PubMed    
    Abstract available
    
    

12. STURZENEGGER N, Schneider SR, Furian M, Titz A, et al
    The Effect of Eccentric Cycling on Cerebral and Muscle Tissue Oxygenation in Patients with Pulmonary Hypertension and Healthy Individuals: A Randomized Controlled Crossover Trial.
    J Clin Med. 2025;14:5751.
    PubMed    
    Abstract available
    
    

13. OLIVEROS E, Jonnalagadda A, Pietrowicz R, Mauri M, et al
    Echo-Doppler Predictors of Residual Pulmonary Hypertension After Pulmonary Thromboendarterectomy.
    J Clin Med. 2025;14:5705.
    PubMed    
    Abstract available
    
    

14. JIANG X, Fei L, Yang Y, Han J, et al
    Effects of Dietary Terpinen-4-ol on Oxidative Stress and Mitochondrial Biogenesis in the Liver of Broilers with Pulmonary Hypertension Syndrome.
    Int J Mol Sci. 2025;26:7702.
    PubMed    
    Abstract available
    
    

15. FANG J, Chen H, Jia Z, Dai J, et al
    miRNAs in Pulmonary Hypertension: Mechanistic Insights and Therapeutic Potential.
    Biomedicines. 2025;13:1910.
    PubMed    
    Abstract available
    
    

16. SIDDA N, Bhat R, Tirlangi P, Pulagam VR, et al
    Unmasking pulmonary veno-occlusive disease after vasodilator therapy in limited cutaneous systemic sclerosis.
    BMJ Case Rep. 2025;18:e266231.
    PubMed    
    Abstract available
    
    

17. SHI JZ, Zhu YJ, Zhang MJ, Yan Y, et al
    Hypoxanthine Promotes Pulmonary Vascular Remodeling and Adenosine Deaminase Is a Therapeutic Target for Pulmonary Hypertension.
    JACC Basic Transl Sci. 2025;10:101273.
    PubMed    
    Abstract available
    
    

18. SCHAFER K
    Increased Generation of Hypoxanthine: How Adaptation of Purine Metabolism Drives Vascular Remodeling in Pulmonary Hypertension.
    JACC Basic Transl Sci. 2025;10:101320.
    PubMed    
    
    
    

19. CAO Y, Koide M, Goto M, Maeda T, et al
    "Treat and repair" strategy for a giant pulmonary artery aneurysm caused by idiopathic pulmonary hypertension and compression of the left main coronary artery.
    Indian J Thorac Cardiovasc Surg. 2025;41:1212-1217.
    PubMed    
    Abstract available
    
    

20. WANG Z, Fu H, Li S
    Revived role of reverse Potts shunt in management of paediatric severe pulmonary hypertension.
    Cardiol Young. 2025 Aug 27:1-10. doi: 10.1017/S1047951125101352.
    PubMed    
    Abstract available
    
    

21. KUSAKA K, Kubo S, Nakayamada S, Miyagawa I, et al
    Association of exercise-induced pulmonary hypertension with nailfold capillary density in systemic sclerosis: a single-center retrospective observational study.
    Arthritis Res Ther. 2025;27:169.
    PubMed    
    Abstract available
    
    

22. AKCA B, Erdil N
    New-Onset Atrial Fibrillation Following Isolated Coronary Artery Bypass Grafting: Is Pulmonary Hypertension a Risk Factor?
    Braz J Cardiovasc Surg. 2025;40:e20240352.
    PubMed    
    Abstract available
    
    

23. CHENG CC, Hsu LF, Chung HH, Lee CW, et al
    IPSC-Derived Conditioned Medium Reduces Oxidative Stress and Vascular Remodeling in Rat Models of Pulmonary Arterial Hypertension.
    J Cell Physiol. 2025;240:e70085.
    PubMed    
    Abstract available
    
    

24. JORNA LM, Nakladal D, van Heuveln JN, van der Feen DE, et al
    SUL-150 Limits Vascular Remodeling and Ventricular Failure in Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2025;26:7181.
    PubMed    
    Abstract available
    
    

25. VANDENBROEK MM, Sharp MC, Thompson P, Fagbola E, et al
    Circular RNA Profiling Identifies circ5078 as a BMPR2-Derived Regulator of Endothelial Proliferation and Stress Responses.
    Arterioscler Thromb Vasc Biol. 2025;45:1546-1561.
    PubMed    
    Abstract available
    
    

26. HUI M, Deng X, Wang J, Qian J, et al
    The association between STAT4 polymorphism and pulmonary arterial hypertension in Chinese patients with primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:3581-3590.
    PubMed    
    Abstract available
    
    

27. SALURSO E, Fiore GB, Vismara R
    Ex Vivo Assessment of Transcatheter Edge-to-Edge Treatment Performance After Pathology Recurrence in Functional Tricuspid Regurgitation.
    Ann Biomed Eng. 2025;53:2178-2191.
    PubMed    
    Abstract available
    
    

28. LAWAL OS, Niihori M, James J, Hinkle AJ, et al
    The Critical Role of HMGB1Cys106 in Regulating Sex-Specific p53 Signaling in Pulmonary Arterial Hypertension.
    Am J Respir Cell Mol Biol. 2025;73:396-414.
    PubMed    
    Abstract available
    
    

29. GE RL
    Medical Problems of Chronic Hypoxia in Highlanders Living on the Tibetan Plateau.
    High Alt Med Biol. 2025;26:308-317.
    PubMed    
    Abstract available
    
    

30. GENTLE SJ, Carlo WA, Ambalavanan N
    Screening for pulmonary hypertension in preterm infants with bronchopulmonary dysplasia: when, how often and does it matter?
    Arch Dis Child Fetal Neonatal Ed. 2025 Sep 5:fetalneonatal-2024-328405.
    PubMed    
    Abstract available
    
    

31. TAKANO R, Tatsuo A, Fujisaki S, Akao M, et al
    Clinical impact of mean pulmonary arterial pressure after balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension.
    Open Heart. 2025;12:e003532.
    PubMed    
    Abstract available
    
    

32. ABEN R, Burton T, Fathieh F, Nemati N, et al
    Facilitating Earlier Diagnosis of Pulmonary Hypertension Using a Novel Noninvasive Diagnostic.
    JACC Case Rep. 2025;30:104876.
    PubMed    
    Abstract available
    
    

33. GARCIA-GOZALO M, Pellicer A, Bravo MC
    Current Practices for Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension in Neonates: A Survey Study in Spain.
    Pediatr Pulmonol. 2025;60:e71259.
    PubMed    
    Abstract available
    
    

34. ABDULAAL LL, Sharkey MMJ, Maiter AA, Alabed SS, et al
    CT scoring system to Defined Thrombus Distribution in Chronic Thromboembolic Pulmonary Hypertension.
    Br J Radiol. 2025 Sep 5:tqaf221. doi: 10.1093.
    PubMed    
    Abstract available
    
    

35. ZICANS M, Sablinskis K, Cesnieks H, Rudzitis A, et al
    Chronic Thromboembolic Pulmonary Hypertension in Latvia: Epidemiological Insights and Diagnostic Challenges From 2024.
    Pulm Circ. 2025;15:e70159.
    PubMed    
    Abstract available
    
    

36. HUMPL T, Berger RMF, Bonnet D, Beghetti M, et al
    How Is Pulmonary Hypertension Characterised and Treated in Children With Trisomy 21? Observations From the TOPP Registry (Tracking Outcomes and Practice in Pediatric Pulmonary Hypertension).
    Pulm Circ. 2025;15:e70146.
    PubMed    
    Abstract available
    
    

37. TOUIL A, Bouden S, Maazaoui S, Rouached L, et al
    Rituximab treatment for connective tissue diseases associated-pulmonary hypertension: a systematic literature review.
    Expert Rev Respir Med. 2025 Sep 4. doi: 10.1080/17476348.2025.2557634.
    PubMed    
    Abstract available
    
    

38. NICCUM M, Avitabile CM, Albizem D, Meluskey H, et al
    Pulmonary Vascular Compromise Is Associated With Survival in Pediatric Pulmonary Hypertension: A New Computational Model.
    Pulm Circ. 2025;15:e70156.
    PubMed    
    Abstract available
    
    

39. GOPALAKRISHNA H, Nguyen ML, Mironova M, Viana Rodriguez GM, et al
    Cardiopulmonary changes and its association with clinical features in noncirrhotic portal hypertension.
    World J Gastroenterol. 2025;31:109256.
    PubMed    
    Abstract available
    
    

40. CASTILLO-TELLO C, Barron-Magdaleno C, Orihuela-Sandoval C, Gutierrez-Leon E, et al
    Parkes Weber syndrome, a rare case of pulmonary hypertension: a case report.
    Eur Heart J Case Rep. 2025;9:ytaf381.
    PubMed    
    Abstract available
    
    

41. ZHENG R, Tan J, Cao X, Wang S, et al
    Rewriting the vascular script: epigenetic modifiers as scribes of metabolic reprogramming in pulmonary hypertension.
    J Mol Med (Berl). 2025 Sep 3. doi: 10.1007/s00109-025-02589.
    PubMed    
    Abstract available
    
    

42. YAMAMURA A
    Growth factors involved in vascular remodeling in pulmonary arterial hypertension.
    J Smooth Muscle Res. 2025;61:82-92.
    PubMed    
    Abstract available
    
    

43. ETO M, Yamazawa T, Kurahara LH, Yamamura A, et al
    Expanding diverse horizons in smooth muscle research: a symposium review of "Muscle and Pathology/Health: Frontiers of Translational Research" at the 66th Annual Meeting of Japan Society of Smooth Muscle Research.
    J Smooth Muscle Res. 2025;61:59-64.
    PubMed    
    Abstract available
    
    

44. DAGHER C, Akiki M, Clark M, Parikh R, et al
    Neuropsychiatric reaction to treprostinil in pulmonary hypertension leading to treatment discontinuation.
    BMJ Case Rep. 2025;18:e266704.
    PubMed    
    Abstract available
    
    

45. RIBEIRO IC, Sieczkowska SM, Jashchenko R, Jara D, et al
    Effectiveness and safety of home-based versus centre-based exercise programmes for pulmonary hypertension: a systematic review with meta-analysis.
    Eur Respir Rev. 2025;34:250102.
    PubMed    
    Abstract available
    
    

46. NA SW, Kim HY, Yoon JJ, Hong MH, et al
    Therapeutic effects of Gunryeong-tang on the cardio-renal axis in an animal model of pulmonary hypertension.
    Integr Med Res. 2025;14:101218.
    PubMed    
    Abstract available
    
    

47. KRISHNAN S, Ramalingam V, Adigopula S, Gadeela N, et al
    Prevalence of Pulmonary Hypertension in Patients With Pulmonary Langerhans Cell Histiocytosis: A Systematic Review and Meta-Analysis.
    Cureus. 2025;17:e89111.
    PubMed    
    Abstract available
    
    

48. POKIMA N, Gill S, Moradi R, Thida AM, et al
    Pulmonary Hypertension in Sickle Cell Disease: A Case Series.
    Cureus. 2025;17:e89012.
    PubMed    
    Abstract available
    
    

49. HARDY L, D'Haenens A, Belmans A, Quarck R, et al
    Renal Outcomes After Lung or Combined Heart-Lung Transplantation in Pulmonary Hypertension.
    Pulm Circ. 2025;15:e70136.
    PubMed    
    Abstract available
    
    

50. LIU Y, Guo X, Liu P, Jia S, et al
    Rehabilitation applications and progress in managing pulmonary hypertension.
    Front Med (Lausanne). 2025;12:1659818.
    PubMed    
    Abstract available
    
    

51. VERBELEN T, Fadel E, Wiedenroth CB, Jenkins DP, et al
    Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: Technical challenges and controversies.
    JHLT Open. 2025;10:100357.
    PubMed    
    Abstract available
    
    

52. MA J, Li W, Xu S, Ren R, et al
    Noninvasive assessment of pulmonary vascular resistance: a synergistic approach using computed tomography pulmonary angiography and echocardiography in pulmonary hypertension.
    Quant Imaging Med Surg. 2025;15:8567-8578.
    PubMed    
    Abstract available
    
    

53. FARANDZHA D, Gatzov P, Velchev V
    Massive Right Atrium due to Severe Pulmonary Hypertension Mimicking Biatrial Enlargement on ECG.
    Clin Case Rep. 2025;13:e70835.
    PubMed    
    Abstract available
    
    

54. ABDALLAH N, Mohamoud A
    Exploring the Relationship between Group 2 Pulmonary Hypertension and Complete Heart Block: A United States Population Based Study.
    Catheter Cardiovasc Interv. 2025 Sep 2. doi: 10.1002/ccd.70134.
    PubMed    
    Abstract available
    
    

55. FARAG MM, Ghazal HAE, Abdel-Mohsen AM, Rezk MA, et al
    Nebulized nitroglycerin as an adjuvant drug in management of persistent pulmonary hypertension of newborns: a randomized controlled trial.
    Eur J Pediatr. 2025;184:586.
    PubMed    
    Abstract available
    
    

56. SCHMERMUND BN, Rieth AJ, Rademann M, Borst PC, et al
    Abnormal Left Atrial Strain by CMR is Associated with Left Heart Disease in Patients with Pulmonary Hypertension.
    Circ Heart Fail. 2025 Aug 31. doi: 10.1161/CIRCHEARTFAILURE.125.013480.
    PubMed    
    Abstract available
    
    

57. ABBAS MT, Farina JM, Mahmoud AK, Wraith RE, et al
    Right ventricular strain enhances the REVEAL LITE score for predicting 1-Year mortality in pulmonary hypertension.
    Int J Cardiovasc Imaging. 2025 Aug 30. doi: 10.1007/s10554-025-03506.
    PubMed    
    Abstract available
    
    

58. DE CASTRO AL, Turck P, Tavares AMV, Gaspar CJ, et al
    Evaluation of the use of the myocardial performance index as a parameter of cardiac function in two experimental models of heart disease: myocardial infarction and pulmonary hypertension.
    Pflugers Arch. 2025 Aug 30. doi: 10.1007/s00424-025-03117.
    PubMed    
    Abstract available
    
    

59. HUNGERFORD SL, Gulati G, Everett K, Kearney K, et al
    Assessment of Ventriculo-Arterial Interactions in Early and Undifferentiated Pulmonary Hypertension Using Wave Intensity Analysis.
    J Am Heart Assoc. 2025 Aug 29:e042831. doi: 10.1161/JAHA.125.042831.
    PubMed    
    Abstract available
    
    

60. ARSHAD A, Melin M, Lund LH, Manouras A, et al
    Assessing the accuracy of echocardiographic estimation of pulmonary pressures: Insights from a 5-grade tricuspid regurgitation classification.
    Int J Cardiol. 2025;440:133729.
    PubMed    
    Abstract available
    
    

61. EL-KERSH K, Zawadzki N, Watzker A, Zhang S, et al
    A structured approach for identifying disease analogs for pulmonary arterial hypertension.
    J Manag Care Spec Pharm. 2025;31:909-921.
    PubMed    
    Abstract available
    
    

62. ALHARBI A, Biyari A, Basuwdan A, Alrodiman O, et al
    Prognostic performance of the 3- and 4-strata ESC/ERS risk stratification models in Pulmonary Arterial Hypertension: A validation study in a Saudi Arabian cohort.
    Respir Med. 2025;247:108257.
    PubMed    
    Abstract available
    
    

63. LIU Z, Cui B, Ju H, Tan T, et al
    Catestatin alleviates PASMC phenotypic switching-mediated pulmonary arterial remodeling in a rat model of MCT-induced pulmonary arterial hypertension by promoting endothelium-derived no synthesis.
    Nitric Oxide. 2025;158:93-105.
    PubMed    
    Abstract available
    
    

64. CONNELLY D, Delahanty J, Patel S, Ackerbauer KA, et al
    Inhaled epoprostenol for management of acute respiratory failure and pulmonary vascular disease.
    Pulm Pharmacol Ther. 2025;90:102374.
    PubMed    
    Abstract available
    
    

65. RAVINDRAN JV, Chung T, Naoum C, Yiannikas J, et al
    Prominent V waves in right heart catheterisation as a marker of left atrial stiffness in pulmonary hypertension.
    Open Heart. 2025;12:e003399.
    PubMed    
    Abstract available
    
    

66. BERGSTROM E, Pola K, Kjellstrom B, Toger J, et al
    Increased contractility affects left ventricular kinetic energy in pulmonary hypertension.
    Physiol Rep. 2025;13:e70563.
    PubMed    
    Abstract available
    
    

67. ELATTAR S, Basha NR, Salem A, Abdulfattah AY, et al
    Tadalafil for Treatment of Pulmonary Hypertension: Mechanisms, Evidence, and Emerging Perspectives.
    Cardiol Rev. 2025 Sep 12. doi: 10.1097/CRD.0000000000001036.
    PubMed    
    Abstract available
    
    

68. WANG S, Yang P, Xi H, Yin X, et al
    Case Report: Shared manifestation, distinct etiologies: severe pulmonary hypertension in both mother and neonate.
    Front Pediatr. 2025;13:1612410.
    PubMed    
    Abstract available
    
    

69. GU W, Li L, Ahmad A, Lv J, et al
    A Machine Learning-Based Model to Estimate the Risk of Pulmonary Hypertension in Chronic Kidney Disease Patients.
    J Clin Hypertens (Greenwich). 2025;27:e70132.
    PubMed    
    Abstract available
    
    

70. BRAND J, de Graaf W, Geiser T, Martinelli M, et al
    Frailty in pulmonary hypertension: Establishing the frailty index and impact on survival.
    Respir Med. 2025;248:108346.
    PubMed    
    Abstract available
    
    

71. VAHDATPOUR C, Virk S, Ding H, Epstein S, et al
    Morning Larks and Night Owls: Considering Chronotype in Evaluation of Patients with Pulmonary Hypertension.
    Ann Am Thorac Soc. 2025 Sep 10. doi: 10.1513/AnnalsATS.202502.
    PubMed    
    Abstract available
    
    

72. LELKOVA K, Hadova K, Katanova M, Babiakova J, et al
    Pleural Effusion Formation Linked to Altered Transporter Expression Involved in Alveolar Fluid Clearance: Insights From the Monocrotaline Model of Pulmonary Hypertension.
    Basic Clin Pharmacol Toxicol. 2025;137:e70096.
    PubMed    
    Abstract available
    
    

73. CHIOU FR, Sung SH, Chiu JH, Guo CY, et al
    Cardiac magnetic resonance parameters for prognostic stratification in pulmonary hypertension: A longitudinal study.
    J Chin Med Assoc. 2025 Sep 10. doi: 10.1097/JCMA.0000000000001292.
    PubMed    
    Abstract available
    
    

74. CAO JJL, Reddy YNV
    Evaluation of pulmonary hypertension in heart failure with preserved ejection fraction.
    Heart Fail Rev. 2025 Sep 9. doi: 10.1007/s10741-025-10553.
    PubMed    
    Abstract available
    
    

75. LIN H, Sun F, Wang L, Gong SG, et al
    [Anti-EJ antibody positive antisynthetase syndrome with pulmonary hypertention:a case report].
    Zhonghua Jie He He Hu Xi Za Zhi. 2025;48:853-855.
    PubMed    
    Abstract available
    
    

76. BIRSIN Z, Salihoglu A, Tokdil KO, Pirdal BZ, et al
    Is splenectomy one of the contributory factors to pulmonary hypertension? An analysis of splenectomized hemolytic anemia and immune thrombocytopenia patients.
    Ann Hematol. 2025 Sep 9. doi: 10.1007/s00277-025-06583.
    PubMed    
    Abstract available
    
    

77. HUDEC M, Januska J, Jiravsky O, Miklik R, et al
    Impact of pulmonary hypertension dynamics and residual mitral regurgitation shortly after M-TEER on long-term outcomes: insights from a prospective registry.
    Clin Res Cardiol. 2025 Sep 8. doi: 10.1007/s00392-025-02747.
    PubMed    
    Abstract available
    
    

78. ERTAN HARPUTLU O, Kuran Aslan G, Akinci B, Bilge AK, et al
    Investigation of different field tests in relation to balance, daily living activities, and quality of life in pulmonary hypertension.
    Monaldi Arch Chest Dis. 2025 Sep 8. doi: 10.4081/monaldi.2025.3308.
    PubMed    
    Abstract available
    
    

79. MAJMUNDAR M, Patel KN, Khawaja T, Doshi R, et al
    Impact of mode of delivery on maternal and fetal outcomes in pregnant patients with heart failure or pulmonary hypertension.
    Am J Prev Cardiol. 2025;23:101263.
    PubMed    
    Abstract available
    
    

80. ZHANG X, Peng M, Ren R, Li W, et al
    Pulmonary hypertension secondary to Abernethy malformation with left inferior vena cava: a case report and literature review.
    Front Med (Lausanne). 2025;12:1604853.
    PubMed    
    Abstract available
    
    

81. GONG X, Min F, Guo J, Zhang Z, et al
    Mechanism of Tetrandrine in Ameliorating Hypoxic Pulmonary Hypertension Vascular Remodeling through Transcriptomics and Metabolomics.
    Curr Drug Metab. 2025 Sep 3. doi: 10.2174/0113892002393801250812063417.
    PubMed    
    Abstract available
    
    

82. DENG F, Sun J, Liu L, Zhang M, et al
    The Predictive Value of Monocyte-to-HDL Cholesterol Ratio in Patients with Dilated Cardiomyopathy and Associated Pulmonary Hypertension.
    Cardiovasc Hematol Agents Med Chem. 2025.
    PubMed    
    Abstract available
    
    

83. SYNN AJ, Nardelli P, Renapurkar R, Quesada L, et al
    Spatial heterogeneity and distribution of CT-Based pulmonary vascular volumes in chronic thromboembolic pulmonary hypertension.
    Eur J Radiol. 2025;192:112405.
    PubMed    
    Abstract available
    
    

84. HINOJOSA W, Velazquez-Martin M, Coronel ML, Segura de la Cal T, et al
    Prognostic value of longitudinal QTc interval analysis in pulmonary arterial hypertension.
    Int J Cardiol. 2025;441:133816.
    PubMed    
    Abstract available
    
    

85. ZHANG C, Song Z, Zhao Y, Guo X, et al
    The underexplored pulmonary toxicity of pyrrolizidine alkaloids: Emerging hazard from food contamination.
    Chem Biol Interact. 2025;420:111709.
    PubMed    
    Abstract available
    
    

86. GIULIANI L, D'Alto M, Di Poi E, Dagna L, et al
    Evaluation of non-invasive low-risk criteria in patients with connective tissue disease-associated pulmonary arterial hypertension: A 12-months analysis from the INSPECTIO study.
    Vascul Pharmacol. 2025;160:107529.
    PubMed    
    Abstract available
    
    

87. SANTOS IA, Graca IS, Placido R, Nogueira G, et al
    Kartagener's syndrome with congenital heart defect-an old rare disease with a new rare face.
    Cardiol Young. 2025;35:1734-1739.
    PubMed    
    Abstract available
    
    

88. PENCHARZ D, Pliszka R, Peters AM
    The effect of Tc-99m-macroaggregated albumin administration on pulmonary vascular resistance.
    Nucl Med Commun. 2025;46:1013-1017.
    PubMed    
    Abstract available
    
    

89. ABDULELAH M, Ezenna C, Jenil-Franco A, Jamouss KT, et al
    Clinical outcomes and safety of sotatercept in pulmonary arterial hypertension: A systematic review and meta-analysis of randomized controlled trials.
    Vascul Pharmacol. 2025;160:107520.
    PubMed    
    Abstract available
    
    

90. SHEELA C, Bairy S, P A A, Koolwal S, et al
    Cross-sectional study of pulmonary hypertension among patients with chronic obstructive pulmonary disease.
    Monaldi Arch Chest Dis. 2025 Sep 16. doi: 10.4081/monaldi.2025.3534.
    PubMed    
    Abstract available
    
    

91. MAO H, Li CM, Sun B, Ward C, et al
    Inhibition of BMPER Mitigates Pulmonary Hypertension by Modulating LRP1-YAP Interaction in Smooth Muscle Cells.
    Arterioscler Thromb Vasc Biol. 2025 Sep 18. doi: 10.1161/ATVBAHA.124.322189.
    PubMed    
    Abstract available
    
    

92. TAN EFS, Gharti SB, Tan DGS
    A Rare Case of Chronic Thromboembolic Pulmonary Hypertension in an Elderly With Atrial Septal Defect and Eisenmenger Syndrome.
    Cureus. 2025;17:e90281.
    PubMed    
    Abstract available
    
    

93. BIRARDAR B, Valakkada J, Ayappan A, Karamakar D, et al
    Left Ventricular Myocardial Perfusion before Contrast Pool in Ventricular Cavity in Cardiac MRI in Adult Type Anomalous Left Coronary Artery from Pulmonary Artery with Pulmonary Hypertension.
    Indian J Radiol Imaging. 2025;35:599-602.
    PubMed    
    Abstract available
    
    

94. YANG D, Li Q, Yang F, Wang R, et al
    Machine learning-based integration develops an immune-derived signature for diagnosing high-altitude pulmonary hypertension.
    Front Med (Lausanne). 2025;12:1603140.
    PubMed    
    Abstract available
    
    

95. XU G, Zhang R, Huang W, Du X, et al
    Comparative effectiveness of statins for chronic obstructive pulmonary disease patients with pulmonary hypertension: systematic review and network meta-analysis.
    Front Med (Lausanne). 2025;12:1640270.
    PubMed    
    Abstract available
    
    

96. LACOSTE-PALASSET T, Aguado B, Grynblat J, Coulet F, et al
    SOX17 in pulmonary arterial hypertension: from development to clinical phenotype.
    Eur Respir Rev. 2025;34:250081.
    PubMed    
    Abstract available
    
    

97. LEMAY SE, Kuwabara Y, Bonnet S, Potus F, et al
    Cellular senescence in adult pulmonary hypertension: current state and future challenges.
    Eur Respir Rev. 2025;34:250030.
    PubMed    
    Abstract available
    
    

98. TANKERE P, Lajeune E, Mariet AS, Cottenet J, et al
    Long-term in-hospital mortality and chronic thromboembolic pulmonary hypertension after COVID-19-associated pulmonary embolism in France: a nationwide study.
    ERJ Open Res. 2025;11:01387-2024.
    PubMed    
    Abstract available
    
    

99. SUZUKI T, Iwahashi N, Abe T, Komura N, et al
    Clinical Usefulness of Passive Leg Lifting During Right Heart Catheterization for Diagnosing Exercise-Induced Pulmonary Hypertension?- A Pilot Study.
    Circ J. 2025 Sep 13. doi: 10.1253/circj.CJ-25-0515.
    PubMed    
    Abstract available
    
    

100. ADACHI S, Nakano Y, Hirose M
     Ray of Hope for Expanding Hemodynamics Estimation During Exercise Stress Testing in Patients With Pulmonary Hypertension.
     Circ J. 2025 Sep 17. doi: 10.1253/circj.CJ-25-0660.
     PubMed    
     
     
     

101. CHEN MY, Wu CH, Cheng SM, Chen TY, et al
     Effects of Web-Based Symptom Monitoring Program on Symptom Interference, Physical Activity, and Emergency Department Readmissions in Patients With Pre-Capillary Pulmonary Hypertension: Randomized Controlled Trial.
     J Med Internet Res. 2025;27:e76883.
     PubMed    
     Abstract available
     
     

102. WANG X, Tang Z, Wang Z
     Trends, Burden, and Inequality in Neonatal Pulmonary Arterial Hypertension: Global Estimates From 1990 to 2021.
     Pediatr Pulmonol. 2025;60:e71277.
     PubMed    
     Abstract available
     
     

103. AL-BADR MA, Abunada HH, Gill R, Fayed HS, et al
     Bosentan Delivery via Nano Metal-Organic Framework nanoMIL-89 Restores Vascular Homeostasis in Pulmonary Arterial Hypertension.
     Int J Nanomedicine. 2025;20:11045-11060.
     PubMed    
     Abstract available
     
     

104. MA SS, Xing YJ, Zhang JW, Wang J, et al
     [Research progress on the mechanism of T lymphocyte in pulmonary arterial hypertension].
     Zhonghua Xin Xue Guan Bing Za Zhi. 2025;53:1089-1094.
     PubMed    
     
     
     

105. DERENZO M
     Pulmonary thrombectomy and extracorporeal membrane oxygenation: a case study.
     J Extra Corpor Technol. 2025;57:171-173.
     PubMed    
     Abstract available
     
     

106. KACHHWAHA A, Karagyozyan DS, Aluzri N, Vandse R, et al
     Perioperative Management of a Pregnant Patient With Severe Mitral Stenosis and Pulmonary Hypertension for Repeat Cesarean Section: The Role of Standby Extracorporeal Membrane Oxygenation.
     Cureus. 2025;17:e89986.
     PubMed    
     Abstract available
     
     

107. ALRAHIMI JS, Ismail Y, Balubaid H, AlZahrani A, et al
     Echocardiographic Insights into Group 2 Pulmonary Hypertension: Unveiling its Prevalence in Advanced Heart Failure Reduced Ejection Fraction.
     J Cardiovasc Echogr. 2025;35:142-148.
     PubMed    
     Abstract available
     
     

108. ZHONG Y, Yang P, Troncone L, Kovalenko OV, et al
     BMP9 regulates the endothelial secretome to drive pulmonary hypertension.
     bioRxiv [Preprint]. 2025 Sep 11:2025.08.29.673113.
     PubMed    
     Abstract available
     
     

109. DE LA CRUZ PM, Lockett A, Gomes MT, Banerjee S, et al
     Pulmonary Hypertension Promotes Neuroinflammation and Neurodegeneration.
     bioRxiv [Preprint]. 2025 Sep 8:2025.09.02.673803. doi: 10.1101/2025.09.02.673803
     PubMed    
     Abstract available
     
     

110. WIEGAND JL, Thompson JA, Landeck BF, Fierstein JL, et al
     Pulmonary Hypertension Outcomes After Closure of Atrial Septal Defect in Infants With Developmental Lung Disease.
     Pulm Circ. 2025;15:e70164.
     PubMed    
     Abstract available
     
     

111. VARGHESE NP, Ely E, Fombin R, Champion C, et al
     Use of Dupilumab to Treat Cutaneous Complications of Continuous Prostacyclin Infusion in Pulmonary Hypertension: A Case Report and Review of Literature.
     Pulm Circ. 2025;15:e70158.
     PubMed    
     Abstract available
     
     

112. NIEMIEC M, Grabka M, Niemiec R, Filipecki A, et al
     The impact of angiotensin receptor-neprilysin inhibitor on clinical status and hemodynamic parameters in patients with pulmonary hypertension due to heart failure with preserved left ventricular ejection fraction: a case series analysis.
     Pol Arch Intern Med. 2025 Sep 15:17120. doi: 10.20452/pamw.17120.
     PubMed    
     
     
     

113. ZHU T, Xiao X, Li X, Liu Z, et al
     Eupatilin alleviates right ventricular fibrosis in rats with pulmonary hypertension induced by monocrotaline.
     Korean J Physiol Pharmacol. 2025 Sep 15. doi: 10.4196.
     PubMed    
     Abstract available
     
     

114. SANDRIO S, Krebs J, Spanier T, Beck G, et al
     Extracorporeal Life Support in a Porcine Model of Septic Endotoxemia with Acute Pulmonary Hypertension: An Experimental Study.
     J Clin Med. 2025;14:6342.
     PubMed    
     Abstract available
     
     

115. IANCU DG, Cristescu L, Mares RG, Varga A, et al
     Evaluating NT-proBNP-to-Albumin (NTAR) and RDW-to-eGFR (RGR) Ratios as Biomarkers for Predicting Hospitalization Duration and Mortality in Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
     Diagnostics (Basel). 2025;15:2126.
     PubMed    
     Abstract available
     
     

116. JUMAAR C, Pretorius A, Malefane L, Jacobs S, et al
     In vitro models and approaches to study underlying pathways of pulmonary arterial hypertension: a review.
     Biochem Biophys Res Commun. 2025;781:152503.
     PubMed    
     Abstract available
     
     

117. CONDE-CAMACHO R, Tuta-Quintero E, Varon-Vega F, Mugnier J, et al
     Association of hemodynamic and functional variables with pulmonary vasculopathy in lung transplant recipients living at high altitude: A retrospective study.
     Sci Prog. 2025;108:368504251367283.
     PubMed    
     Abstract available
     
     

118. BABU V, Little JA, Morris CR, Machado R, et al
     Targeted Proteomic Analysis of Sickle Cell Disease Patients With Elevated Tricuspid Regurgitation Velocity.
     Proteomics Clin Appl. 2025;19:e70019.
     PubMed    
     Abstract available
     
     

119. TUHY T, Coursen JC, Graves T, Patatanian M, et al
     Lung Single-Cell Transcriptomics Reveal Diverging Pathobiology and Opportunities for Precision Targeting in Scleroderma-Associated Versus Idiopathic Pulmonary Arterial Hypertension.
     Circ Genom Precis Med. 2025 Jul 21:e004936. doi: 10.1161/CIRCGEN.124.004936.
     PubMed    
     Abstract available
     
     

120. WU YS, Malik A, Wang C, Welch C, et al
     Initial Survival and Short-term Pulmonary Comorbidities in Infants with Congenital Diaphragmatic Hernia of Differing Indices of Social Determinants of Health.
     J Pediatr Surg. 2025 Jul 12:162460. doi: 10.1016/j.jpedsurg.2025.162460.
     PubMed    
     Abstract available
     
     

121. SESCLEIFER AM, Chidiac C, Hellmann ZJ, McDermott KM, et al
     REVISITING INHALED NITRIC OXIDE UTILIZATION IN CONGENITAL DIAPHRAGMATIC HERNIA: A NATIONAL COHORT STUDY OF MAJOR CHILDREN'S HOSPITALS IN THE UNITED STATES.
     J Pediatr Surg. 2025 Jun 23:162423. doi: 10.1016/j.jpedsurg.2025.162423.
     PubMed    
     Abstract available
     
     

122. HUNGERFORD SL, Everett K, Lau E, Burkhoff D, et al
     Pulmonary Circulation in Advanced Heart Failure and Cardiogenic Shock: State-of-the-Art Review.
     Circ Heart Fail. 2025 Jun 2:e012611. doi: 10.1161/CIRCHEARTFAILURE.124.012611.
     PubMed    
     Abstract available
     
     

123. KIM Y, Yeo Y, Kim M, Son YW, et al
     A highly mobile adeno-associated virus targeting vascular smooth muscle cells for the treatment of pulmonary arterial hypertension.
     Nat Biomed Eng. 2025;9:1418-1436.
     PubMed    
     Abstract available
     
     

124. LE PAPE A, Guignabert C, Tu L, Mougenot N, et al
     Altered Ventilation in Rats With Established Severe Monocrotaline-Induced Pulmonary Hypertension: The Role of the Dorsal Hypothalamus.
     Compr Physiol. 2025;15:e70055.
     PubMed    
     Abstract available
     
     

125. SHIRAHATA T, Nardelli P, Jesudasen S, San Jose Estepar R, et al
     Detection of pulmonary hypertension in idiopathic pulmonary fibrosis using random forest models and automated measures of central computed tomography structures.
     ERJ Open Res. 2025;11:01057-2024.
     PubMed    
     Abstract available
     
     

126. MCLEAN D, Rommel J, Steuter JA, Carroll WS, et al
     Clinical validation of a machine-learned, point-of-care system to IDENTIFY pulmonary hypertension.
     ERJ Open Res. 2025;11:01287-2024.
     PubMed    
     Abstract available
     
     

127. HEKIMOGLU K, Gopalan D, Onur MR, Kahraman G, et al
     Imaging in chronic thromboembolic pulmonary hypertension: review of the current literature.
     Diagn Interv Radiol. 2025 Sep 23. doi: 10.4274/dir.2025.253249.
     PubMed    
     Abstract available
     
     

128. CHIDA-NAGAI A, Terashita Y, Hirabayashi S, Yamazawa H, et al
     Pediatric Pulmonary Hypertension Associated With Treatment of Myeloproliferative Disorders and Malignant Tumors.
     Pulm Circ. 2025;15:e70165.
     PubMed    
     Abstract available
     
     

129. QIN Y, Sha Z, Qiao Y, Yan G, et al
     Phospholysine phosphohistidine inorganic pyrophosphate phosphatase Suppresses Glycolysis and Proliferation of Pulmonary Artery Smooth Muscle Cells in Hypoxic Pulmonary Hypertension via Inhibition of lactate dehydrogenase A.
     Eur J Pharmacol. 2025 Sep 20:178172. doi: 10.1016/j.ejphar.2025.178172.
     PubMed    
     Abstract available
     
     

130. VAN HEERDEN J, Mbanze I, Louw E, Aremu O, et al
     Technical Challenges in Studying Infectious Disease-Associated Pulmonary Hypertension in Low- and Middle-Income Countries with Limited Resources.
     Infect Dis Rep. 2025;17:109.
     PubMed    
     Abstract available
     
     

131. WANG X, Deng T, Zhu H, Peng J, et al
     Chinese Herbal Medicine in Hypoxic Pulmonary Hypertension Treatment: Mechanisms, Progress, and Future Directions.
     Drug Des Devel Ther. 2025;19:8265-8294.
     PubMed    
     Abstract available
     
     

132. WARSAME R, Ofuya R, Thillai RS, Gollapinni U, et al
     An Unusual Cause of Severe Pulmonary Hypertension: Compression of Pulmonary Arteries by Aortic Aneurysm and Thrombus Formation.
     Cureus. 2025;17:e90653.
     PubMed    
     Abstract available
     
     

133. DAR MM, Nagla I, Kishk R
     Echocardiography-Unmasked Pulmonary Hypertension in Acute Respiratory Distress Syndrome (ARDS): A Fatal Case of Biventricular Failure.
     Cureus. 2025;17:e90366.
     PubMed    
     Abstract available
     
     

134. YE Y, Yin D, Wang Y, Lin J, et al
     Acidosis and in-hospital mortality in patients with pulmonary hypertension: a retrospective cohort study based on the MIMIC-IV database.
     Front Med (Lausanne). 2025;12:1654432.
     PubMed    
     Abstract available
     
     

135. ALQARNI AA, Alghamdi SA, Aldhahir AM, Alqahtani JS, et al
     Drugs targeting the NO-sGC-cGMP pathway in the treatment of patients with COPD-associated pulmonary hypertension: a systematic review.
     Front Pharmacol. 2025;16:1641932.
     PubMed    
     Abstract available
     
     

136. CAI C, Choy JS, He G, Widlansky ME, et al
     Effects of pulmonary hypertension on right ventricular mechanics and coronary perfusion: Insights from computational simulations.
     Comput Biol Med. 2025;197.
     PubMed    
     Abstract available
     
     

137. LOUREIRO CMC, Ferreira EVM, Oliveira RKF, Cordeiro AAAC, et al
     Gas exchange dynamics and responses to exercise in chronic thromboembolic pulmonary hypertension.
     Respir Physiol Neurobiol. 2025 Sep 18:104490. doi: 10.1016/j.resp.2025.104490.
     PubMed    
     Abstract available
     
     

138. XU Y, Yan X, Feng T, Liu Y, et al
     Network toxicology and molecular docking to investigate the association of perfluorooctane sulfonate and pulmonary arterial hypertension via adverse outcome pathways.
     Ecotoxicol Environ Saf. 2025;303:119007.
     PubMed    
     Abstract available
     
     

139. MANCA P, Nuzzi V, Lucchino A, Rugiano G, et al
     Right ventricular global work efficiency: A reliable non-invasive estimate of right ventricular contractility.
     ESC Heart Fail. 2025;12:3719-3730.
     PubMed    
     Abstract available
     
     

140. SUN N, Wang YB, Huang J, Deng RW, et al
     Irisin Attenuates Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension via Ubiquitin-Mediated Regulation of ENO1.
     Adv Sci (Weinh). 2025;12:e00096.
     PubMed    
     Abstract available
     
     

141. LECHUGA CG, Raza F, Colebank MJ, Korcarz CE, et al
     Wave intensity analysis with exercise identifies impairments in pulmonary hypertension.
     Am J Physiol Heart Circ Physiol. 2025 Sep 12. doi: 10.1152/ajpheart.00194.2025.
     PubMed    
     Abstract available
     
     

142. SMITH MA, Guardado ES, Boehme J, Datar SA, et al
     Microvascular preservation and cardiomyocyte hyperplasia underlie adaptive right ventricle development in congenital heart disease-pulmonary arterial hypertension.
     Am J Physiol Heart Circ Physiol. 2025;329:H907-H919.
     PubMed    
     Abstract available
     
     

143. REDDY YNV, Asokan AK, Frantz RP, Hemnes A, et al
     Metabolomic Evidence of Biological Overlap with Heart Failure with Preserved Ejection Fraction in a Subset of Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2025;211:1701-1713.
     PubMed    
     Abstract available
     
     

144. SHLOBIN OA, Piccari L
     A 10,000-Foot View at Survival and Treatment with PDE5 Inhibitors in Interstitial Lung Disease Pulmonary Hypertension.
     Am J Respir Crit Care Med. 2025 Sep 8. doi: 10.1164/rccm.202508-1980.
     PubMed    
     
     
     

145. HILL NS
     In PAH with high risk for death, sotatercept reduced a composite of death, lung transplantation, or PAH hospitalization >24 h at 9 mo.
     Ann Intern Med. 2025;178:JC92.
     PubMed    
     Abstract available
     
     

146. BOUCLY A, Mitrovic S, Carmagnat M, Savale L, et al
     Pulmonary arterial hypertension in adults with Still's disease: another pulmonary manifestation associated with HLA-DRB1*15.
     Ann Rheum Dis. 2025;84:1538-1548.
     PubMed    
     Abstract available
     
     

147. JOSE A, Sood N, Elwing JM, Akkanti B, et al
     "How I Do It": Pulmonary Hypertension Associated with Interstitial Lung Diseases.
     Chest. 2025 Sep 10:S0012-3692(25)05167-0. doi: 10.1016/j.chest.2025.07.4107.
     PubMed    
     Abstract available
     
     

148. SAVONITTO G, Barbisan D, Ameri P, Lombardi CM, et al
     Characteristics, Prognosis, and European Society of Cardiology and European Respiratory Society Risk Stratification in Patients With Obesity and Pulmonary Arterial Hypertension.
     Chest. 2025;168:749-762.
     PubMed    
     Abstract available
     
     

149. KHAN M, Suribhatla R, Spencer J, Daniel N, et al
     Prevalence of Pulmonary Hypertension in Individuals With Heart Failure: A Systematic Review and Meta-Analysis.
     Clin Cardiol. 2025;48:e70197.
     PubMed    
     Abstract available
     
     

150. MORALES-DEMORI R, Ortoleva J, Aras S, Anders M, et al
     Outcomes of Extracorporeal Membrane Oxygenation in Patients with COVID-19 and Pulmonary Hypertension: An ELSO Registry Analysis.
     J Cardiothorac Vasc Anesth. 2025 Aug 6:S1053-0770(25)00653.
     PubMed    
     Abstract available
     
     

151. AHMED U, Mahmood F, Nicoara A, Kiarad V, et al
     Right Ventricular Function and Echocardiographic Pressure-Volume Loops: Overview and Perioperative Clinical Implications.
     J Cardiothorac Vasc Anesth. 2025;39:2857-2865.
     PubMed    
     Abstract available
     
     

152. SCHNEIDER H, Ius F, Muller C, Salman J, et al
     Paediatric Lung Transplantation for Childhood Interstitial Lung Disease: Indications and Outcome.
     J Heart Lung Transplant. 2025 Apr 8:S1053-2498(25)01899.
     PubMed    
     Abstract available
     
     

153. STEWART DJ, Mehta S, Chandy G, Hirani N, et al
     Study of angiogenic cell therapy for progressive pulmonary arterial hypertension: intervention with repeat dosing of eNOS-enhanced EPCs: the SAPPHIRE trial.
     J Heart Lung Transplant. 2025;44:1663-1667.
     PubMed    
     Abstract available
     
     

154. CHEN R, Guo D, Pan J, Pang L, et al
     Comprehensive analysis of disulfidptosis-related genes in pulmonary hypertension through machine learning and immune infiltration: Spotlight on USP32 and ZNF655 as key regulators.
     PLoS One. 2025;20:e0330832.
     PubMed    
     Abstract available
     
     

155. CHEN W, Zhang L, Qi H
     CD44 as a novel therapeutic target in pulmonary arterial hypertension: Insights from multi-omics integration and molecular docking.
     PLoS One. 2025;20:e0332817.
     PubMed    
     Abstract available